Rimonabant impaired olfactory discrimination in mice through TRPV1 receptors in the olfactory bulb rather than through its known CB1 receptor blocking action, revealing an unexpected mechanism for this drug.
Read this if you follow neuroscience research on how the endocannabinoid system affects sensory function.
Rimonabant impairs smell through TRPV1, not CB1 receptors
What the researchers found
Rimonabant is best known as a CB1 cannabinoid receptor blocker, but it also interacts with other receptors. This study investigated its effects on smell, a function increasingly linked to the endocannabinoid system.
CB1 knockout mice showed impaired olfactory discrimination, confirming a role for CB1 in smell. But these mice also showed broader deficits in exploration, making interpretation difficult.
When rimonabant was given to normal mice, either systemically or directly into the olfactory bulb, it impaired olfactory discrimination. The surprise: this impairment was reversed by blocking TRPV1 receptors (using capsazepine), not by activating CB1 receptors. This means rimonabant's effect on smell works through TRPV1, not CB1.
Interestingly, only repeated (not single) doses of rimonabant impaired smell, and neither rimonabant nor the TRPV1 blocker affected general locomotion or exploration.
Why it matters
This study reveals that a drug's effects can be mediated by receptors other than its primary target. For rimonabant specifically, TRPV1-mediated olfactory effects could have contributed to the altered eating behavior seen in clinical use, since smell and taste are closely linked to appetite.
The numbers in context
CB1 knockout mice showed impaired olfactory discrimination. Short-term (but not acute) rimonabant impaired smell in wild-type mice. TRPV1 antagonist capsazepine reversed the olfactory deficit. Neither drug affected locomotion or general exploration in wild-type mice.
How the study worked
Mouse study using CB1 knockout mice and pharmacological approaches. Olfactory discrimination was tested using a habituation-dishabituation paradigm. Rimonabant and the TRPV1 antagonist capsazepine were administered systemically and directly into the olfactory bulb. Locomotion and exploratory behavior were also measured.
What this study cannot tell us
Mouse olfactory systems differ from humans. The TRPV1-mediated mechanism needs confirmation in other species. The study used a specific olfactory discrimination task that may not capture all aspects of olfactory function. CB1 knockout mice had broader behavioral deficits complicating interpretation.
How to read the evidence
Well-designed animal study with both genetic and pharmacological approaches, but limited to mice with uncertain translation to humans.
When this study was published
Published in 2016. The intersection of cannabinoid receptors, TRPV1, and sensory processing remains an active research area.
The bigger picture
Olfaction is being explored as a biomarker for neurological and psychiatric conditions including schizophrenia and autism. Understanding how the endocannabinoid system and related receptors influence smell could have broader diagnostic and therapeutic implications.
Questions still open
- Did rimonabant's effects on smell contribute to its anti-obesity effects through appetite suppression? Could TRPV1 agonists or antagonists be used to modulate olfactory function in neuropsychiatric conditions?
Common questions
Does the endocannabinoid system affect smell?
Why does this matter beyond basic science?
Read the original research
Involvement of TRPV1 in the Olfactory Bulb in Rimonabant-Induced Olfactory Discrimination Deficit.
The Chinese journal of physiology, 59(1), 21-32
Citation
Hu, Sherry Shu-Jung. (2016). Involvement of TRPV1 in the Olfactory Bulb in Rimonabant-Induced Olfactory Discrimination Deficit.. The Chinese journal of physiology, 59(1), 21-32. https://doi.org/10.4077/CJP.2016.BAE366
Explore the wider topic
- How THC Affects Your Amygdala: The Brain's Threat Detector and Cannabis
- The Anandamide Connection: Your Body's Natural Bliss Molecule
- How Long for Cannabinoid Receptors to Return to Normal
- Cannabis and the Developing Brain: What Every Teenager (and Parent) Should Know
- Why Can't I Enjoy Anything Without Weed? The Science Behind It
- Dopamine Recovery After Quitting Weed: What the Science Says
- The Endocannabinoid System Explained Simply: What It Does and Why It Matters
- Your Endocannabinoid System Explained: Why Withdrawal Happens
- Your Nervous System After Quitting Weed: Fight or Flight
- Using Weed Under 18: What It Does to Your Developing Brain
- What THC Does to Your Brain: Why Withdrawal Happens
- THC and Your Prefrontal Cortex: What Cannabis Does to Your Decision-Making Brain
- Weed, Cortisol, and Stress: What Cannabis Does to Your Stress Hormones
- Weed and Memory: What the Science Says About THC and Your Hippocampus
- Weed and Motivation: Is Amotivational Syndrome Real?
- Weed and Your Nervous System: What THC Actually Does to Your Brain and Body
- How Weed Rewires Your Reward System (And How to Reset It)